Evaluation and Clinical Epidemiology Department, Parc de Salut Mar, Barcelona, Catalonia, Spain.
PLoS One. 2012;7(1):e30157. doi: 10.1371/journal.pone.0030157. Epub 2012 Jan 17.
Reductions in breast cancer (BC) mortality in Western countries have been attributed to the use of screening mammography and adjuvant treatments. The goal of this work was to analyze the contributions of both interventions to the decrease in BC mortality between 1975 and 2008 in Catalonia.
METHODOLOGY/PRINCIPAL FINDINGS: A stochastic model was used to quantify the contribution of each intervention. Age standardized BC mortality rates for calendar years 1975-2008 were estimated in four hypothetical scenarios: 1) Only screening, 2) Only adjuvant treatment, 3) Both interventions, and 4) No intervention. For the 30-69 age group, observed Catalan BC mortality rates per 100,000 women-year rose from 29.4 in 1975 to 38.3 in 1993, and afterwards continuously decreased to 23.2 in 2008. If neither of the two interventions had been used, in 2008 the estimated BC mortality would have been 43.5, which, compared to the observed BC mortality rate, indicates a 46.7% reduction. In 2008 the reduction attributable to screening was 20.4%, to adjuvant treatments was 15.8% and to both interventions 34.1%.
CONCLUSIONS/SIGNIFICANCE: Screening and adjuvant treatments similarly contributed to reducing BC mortality in Catalonia. Mathematical models have been useful to assess the impact of interventions addressed to reduce BC mortality that occurred over nearly the same periods.
西方国家乳腺癌(BC)死亡率的降低归因于筛查性乳房 X 光摄影术和辅助治疗的应用。本研究的目的是分析这两种干预措施对 1975 年至 2008 年期间加泰罗尼亚乳腺癌死亡率降低的贡献。
方法/主要发现:采用随机模型来量化每种干预措施的贡献。在四个假设情景中估计了 1975 年至 2008 年日历年度的年龄标准化乳腺癌死亡率:1)仅筛查,2)仅辅助治疗,3)两种干预措施,以及 4)无干预。对于 30-69 岁年龄组,观察到的加泰罗尼亚每 10 万妇女年的乳腺癌死亡率从 1975 年的 29.4 上升到 1993 年的 38.3,之后持续下降到 2008 年的 23.2。如果两种干预措施都未使用,那么在 2008 年估计的乳腺癌死亡率将为 43.5,与观察到的乳腺癌死亡率相比,这表明降低了 46.7%。2008 年,筛查的降低归因于 20.4%,辅助治疗为 15.8%,两种干预措施的综合降低为 34.1%。
结论/意义:筛查和辅助治疗同样有助于降低加泰罗尼亚的乳腺癌死亡率。数学模型已被证明可用于评估在几乎相同时期实施的旨在降低乳腺癌死亡率的干预措施的影响。